dihydronarciclasine has been researched along with Leukemia, Myeloid, Acute in 1 studies
*Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, CG; Kim, BK; Kim, ES; Kim, JY; Kim, SJ; Lee, YY; Park, BB; Park, HK; Yoon, JS | 1 |
1 other study(ies) available for dihydronarciclasine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Anti-leukemic effect of a synthetic compound, (±) trans-dihydronarciclasine (HYU-01) via cell-cycle arrest and apoptosis in acute myeloid leukemia.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Proliferating Cell Nuclear Antigen; Protein Binding; Signal Transduction | 2012 |